The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines
Abstract
OBJECTIVE: In patients with Cushing's syndrome (CS) cardiovascular complications determine a mortality rate four times higher than in an age- and gender-matched population. Therefore, we calculated the global cardiovascular risk in patients with CS. DESIGN AND PATIENTS: We applied the World Health Organization--International Society of Hypertension (WHO/ISH) 1999 guidelines for the estimation of cardiovascular risk in 38 females and 11 males with CS; 27 pituitary adenomas, 15 adrenal adenomas, four adrenal carcinomas and three ectopic ACTH-secreting tumours. The risk of major cardiovascular events was estimated considering the combined effect of several risk factors (hypertension, diabetes, etc.), organ damage (left ventricular hypertrophy (LVH), proteinuria, etc.) and associated pathologies. Four categories of absolute cardiovascular disease risk were defined (low, medium, high, very high). RESULTS: Eighty per cent of patients presented a 'high' or 'very high' cardiovascular risk; 85.1% of the patients were hypertensive with a mild-moderate hypertension (68%). Forty-seven per cent of patients were diabetics and 41.3% were obese. Hyperlipidaemia was less frequent (37.5%). Fasting glycaemia was the only cardiovascular risk factor that correlated with a degree of hypercortisolism. Duration of disease correlated with the presence of obesity (P < 0.0008) and hypertension (P < 0.03) but not with the presence of diabetes or dyslipidaemia and seemed to be the only significant predictor of cardiovascular risk (P = 0.03). CONCLUSIONS: Patients with active CS present a remarkably increased cardiovascular risk. Considering that the biochemical cure of hypercortisolism is often difficult to obtain, especially in Cushing's disease, and that cardiovascular risk could persist even after the 'cure', control of risk factors should be one of the primary goals of the therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From % to % of patients with endogenous CS have DM, and % to % have defective glucose tolerance, so the overall prevalence of glucose metabolism impairments can come close to %, as shown in Table (, , -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [185]
In the citing paper
“Fasting plasma glucose (FPG) level may not suffice to assess glucose homeostasis in CS because more than one in two patients (%) with endogenous CS and DM have normal FGP levels () and because an oral glucose tolerance test (OGTT) is not always performed in patients with apparently normal fasting glycemia ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [185]
In the citing paper
“Diabetes can develop irrespective of the etiology of cortisol excess in patients with endogenous CS (, ), and its onset does not seem to correlate with the duration of the latter disease ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [185]
In the citing paper
“Generally speaking, the severity of hypercortisolism correlates with the presence of IR and DM, as evidenced by an association with higher urinary free cortisol (UFC) levels (, ), though this was not identified in all studies (, ).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [185]
Citations
Cites
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,226
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
MACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253 · cited 2×
“Blood pressure levels, both systolic and diastolic, have been shown to be positively and continuously related to the risk of stroke across a wide range of levels in populations (MacMahon et al., 1990).”
BackgroundSubcommittee, G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,921
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationProspective Studies Collaboration, & Kromhout, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 851
Rimm, E. B., Stampfer, M. J., Giovannucci, E. L., Ascherio, A., Spiegelman, D. L., Colditz, G. A., & Willett, W. C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117385 · Cited by 840
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- 10.1046/j.1563-2571.2000.200106.x · DOI · Paper page
- 10.1210/jc.87.8.3662 · DOI
- 10.1210/jc.84.8.2664 · DOI
- 10.1210/jc.86.11.5301 · DOI
- Laragh J.H., 1995, Hypertension: Pathophysiology, Diagnosis and Management, 1987
Cited by
Sorted by citations
Items 201–278 of 278
Chacko, S. R., Sharma, S. S., Ahmadian, S., Saini, J., Fell, V. M., Peersen, A. F., Atkinson, E. J., Gruber, L., Gompel, J. J. V., Simha, V., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf693 · Cited by 3
Pasireotide for the treatment of Cushing's disease
Colao, A., Simeoli, C., de Leo, M., Cozzolino, A., & Pivonello, R. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.807731 · Cited by 2
Endocrine Disorders and Dyslipidemia
Hong, Y. S. (2008) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2008.23.1.9 · Cited by 3
Takenouchi, H., Anno, T., Iwamoto, H., Takahashi, K., Iwamoto, Y., Horiya, M., Kimura, Y., Kawasaki, F., Kaku, K., Tomoda, K., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.8665-21 · Cited by 3
Obesity-Related Hemodynamic Alterations in Patients with Cushing’s Disease
Jurek, A., Krzesiński, P., Uziębło‐Życzkowska, B., Witek, P., Zieliński, G., Wierzbowski, R., Kazimierczak, A., Banak, M., & Gielerak, G. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061658 · Cited by 3
Cushing’s syndrome and COVID-19
Attia, A., & Bertherat, J. Y. (2024) · Pituitary · doi:10.1007/s11102-024-01466-0 · Cited by 3
Cushing’s glucocorticoid syndrome in the practice of a rheumatologist (A review of literature)
Satybaldyev, A. M. (2013) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2013-2443 · Cited by 3
Transsphenoidal Microsurgery for Cushing's Disease: Initial Outcome and Long-term Results
Molitch, M. E. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70476-1 · Cited by 3
Update on Hypercortisolism Therapy
Arnaldi, G., & Trementino, L. (2016) · Frontiers of hormone research · doi:10.1159/000443869 · Cited by 3
Self-citationHamidi, O., St-Jean, M., Lacroix, A., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag095 · Cited by 5
Frailty and pituitary surgery: a systematic review
Castle‐Kirszbaum, M., McCormack, A. I., Ovenden, C. D., Kam, J. K. T., King, J. A. J., Wang, Y. Y., & Goldschlager, T. (2025) · Pituitary · doi:10.1007/s11102-025-01507-2 · Cited by 4
Hypothalamic-Pituitary-Adrenal Axis
Wirtz, P. H. (2022) · Springer eBooks · doi:10.1007/978-0-387-85960-6_39 · Cited by 2
José, P. G. S., Alenza, M. D. P., Alonso‐Miguel, D., Sanz, S., & Arenas, C. (2024) · Animals · doi:10.3390/ani14030511 · Cited by 2
Salvio, G., Ciarloni, A., Aboud, N., Ambo, N., Bordoni, M., Lucchetti, B., Martino, M., Perrone, M., Gasparroni, M., Balercia, G., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf681 · Cited by 2
Self-citationSurgical Treatment of Cushing’s Disease
Tierney, T. S., & Swearingen, B. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_9 · Cited by 2
Khodakova, I. V., Arapova, S., Sukhanova, G., Chirkova, L., & Rozhinskaia, L. (2010) · Problems of Endocrinology · doi:10.14341/probl201056434-38 · Cited by 1
BERTAGNA, X. Y., Guignat, L., Raux-Demay, M. C., Guilhaume, B., & Girard, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10016-1 · Cited by 2
Hormone Excess Syndromes of the Hypothalamic-Pituitary Axis
Agrawal, N., Kim, H. H., Wright, K. E., & Mehta, S. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_10 · Cited by 2
Cushing’s Disease – Quality of Life, Recurrence and Long-term Morbidity
Huguet, I., Ntali, G., Grossman, A. B., & Karavitaki, N. (2015) · US Endocrinology · doi:10.17925/use.2015.11.1.55 · Cited by 2
QT interval instability and variability in dogs with naturally-occurring hypercortisolism
Vila, B. D. C. P., Vanhoni, M. S., & Sousa, M. G. (2022) · Veterinary Research Communications · doi:10.1007/s11259-022-09936-1 · Cited by 2
Modern principles of the diagnosis and conservative treatment of Cushing disease
Abdali, A., Astafeva, L., Kalinin, P., Trunin, Y., Chernov, I., Сhmutin, G. E., Badshahzar, A., Sherzad, G., & Keith, S. (2020) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2010-08 · Cited by 1
The Endocrine System and Metabolic Complications in Anesthesia
Miller, A., McGinnis, T., & Sreedharan, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-60203-0_23 · Cited by 1
Benhacene, W., Cherrada, N., Zekhemi, Z., Souttou, S., Rezik, K. N., Benabdesselam, R., Aziz, T. A., Shami, A., Alwethaynani, M. S., Al‐Joufi, F. A., et al. (2026) · Open Chemistry · doi:10.1515/chem-2025-0222 · Cited by 1
Systemic and cardiac pathology induced by a clinically relevant USP8 activating mutation
González, T., Galicia-Martín, A., Calle, D., Cussó, L., Soto‐Navarrete, M. T., Luo, X., Méndez-Peralta, L., Grego‐Bessa, J., & de la Pompa, J. L. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052695 · Cited by 1
Type 2 Diabetes and Concomitant Illness
Dungan, K. M., Harris, E., & Braithwaite, S. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_14 · Cited by 1
Mood Disorders and Cardiovascular Disease
Jennifer, L., Lavoie, K., Arsenault, A., Ditto, B., & Simon, L. S. (2012) · InTech eBooks · doi:10.5772/33278 · Cited by 1
Tabti, E., Benmekki, A., Bestaoui, M. H., Messaad, M., Ghembaza, A., & Lounici, A. (2018) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2018.05.001 · Cited by 1
Using Continuous Glucose Monitoring for Steroid-Induced Diabetes
Lu, J., & Jia, W. (2018) · Springer eBooks · doi:10.1007/978-981-10-7074-7_17 · Cited by 1
Extracellular Vesicles and Hypertension
Tang, H., Hu, Y., & Deng, J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_5 · Cited by 1
Diabetes mellitus type 2: a new indication for hypercortisolism screening?
Волкова, Н. И., Antonenko, M. I., & Ganenko, L. A. (2012) · Diabetes Mellitus · doi:10.14341/2072-0351-5545 · Cited by 1
DIABETES MELLITUS IN NEUROENDOCRINE DISEASES
Trigolosova, I. V., Виноградова, А. В., & Kruglyakova, M. (2016) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2014-32-89-96 · Cited by 1
Physiopathology, Diagnosis, and Treatment of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Endocrinology · doi:10.1007/978-3-319-44444-4_12 · Cited by 1
Ragnarsson, Ó. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00006-6 · Cited by 1
Rationale to search for masked hypertension in severe Cushing's disease
Koracevic, G. P., STOJANOVIC, M. S., STOJANOVIC, S. S., Lović, D. B., & Djordjević, M. (2023) · Minerva Medica · doi:10.23736/s0026-4806.19.06327-4 · Cited by 1
Endocrine Aspects of the Metabolic Syndrome
Holt, R. I. G., & Sönksen, P. H. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch8 · Cited by 1
Long-Term Complications of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64305-2 · Cited by 1
Transsphenoidal Microsurgery for Cushing's Disease: Initial Outcome and Longterm Results
Molitch, M. E. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70619-9 · Cited by 1
Diabetes Secondary to Endocrinopathies
Silverstein, J. M., Sterl, K., Cartier, J. L., Cruz‐Bravo, P., Davis, C., Sadiq, S., & McGill, J. B. (2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.ch05 · Cited by 1
Ходакова, Ю. В., Рожинская, Л. Я., Суханова, Г. А., Arapova, S., Ильин, А. В., Чиркова, Л. Д., & Савельева, Л. В. (2012) · CyberLeninK (CyberLeninka)
Endogenous hypercorticism as a prothrombogenic state
Khodakova, I. V., Rozhinskaia, L., Sukhanova, G., Arapova, S., Il'in, A., & Chirkova, L. (2012) · Problems of Endocrinology · doi:10.14341/probl20125813-8
Ходакова, Ю. В., Rozhinskaya, L. Y., Suhanova, G. A., Arapova, S., Ильин, А. В., Chirkova, L. D., & Савельева, Л. В. (2012) · Obesity and metabolism · doi:10.14341/2071-8713-5051
Apport de l’orientation clinique dans le diagnostic des hypertensions arterielles endocriniennes
Aziz, S. E., Chadli, A., Louda, F., Ghomari, H. E., & Farouqi, A. (2014) · Pan African Medical Journal · doi:10.11604/pamj.2014.18.171.1619
Hipercortisolismo de origen suprarrenal: síndrome de Cushing
Blasco, F. Á., Buesa, M. A., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70398-0
Newell-Price, J. D. C., BERTAGNA, X. Y., Grossman, A. B., & Nieman, L. K. (2006)
MÁSTER EN INVESTIGACIÓN BIOMÉDICA TRASLACIONAL
Castano, J. P., Luque, R. M., & Gahete, M. D. (2013)
Cushing[apos]s syndrome and dyslipidaemia
Azzoug, S., Rabehi, L., Hannachi, S., Medjdoubi, H., & Chentli, F. (2015) · Endocrine Abstracts · doi:10.1530/endoabs.37.ep28
Гл юкокортикоидный синдром Кушинга в практике ревматолога (обзор литературы)
Satybaldyev, A. M., & Nasonova, V. A. (2013)
Long-Term Effects of Prior Cushing’s Syndrome
Aulinas, A., Valassi, E., Resmini, E., Vives, A. S., Crespo, I., Barahona, M. J., & Webb, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_11
McLaughlin, N., Kassam, A. B., Prevedello, D. M., & Kelly, D. F. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_13
A Case of Cushing’s Syndrome Presented with Severe Heart Failure and Multiple Vertebral Fractures
Arduç, A., Işık, S., Akbaba, G., Küçükler, K., Berker, D. S., & Güler, S. (2015) · Medical Bulletin of Haseki · doi:10.4274/haseki.2473
Adrenal Cushing’s Syndrome: Updates on Overt and Mild Hypercortisolism
Escobar, J. S., Ravikumar, A., & Levine, A. C. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_10
Physiopathology, Diagnosis, and Treatment of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2017) · Endocrinology · doi:10.1007/978-3-319-38681-2_12-1
Endocrine Causes of Hypertension
Richards, M., & Nicholls, M. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00039-3
Adrenal Adenoma Causing Secondary Hypertension. A Review of the Literature
Lounici, A., Tabti, E., Benmekki, A., & Bestaoui, M. H. (2018) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/5/6/001122
Analysis of Clinical Characteristics of Glucose Metabolism in 118 Patients with Cushing’s Syndrome
怀, 宙. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.113142
QT Interval Instability and Variability in Dogs with HyperadrenocorticismPreprint
Vila, B. D. C. P., Vanhoni, M. S., & Sousa, M. G. (2021) · Research Square · doi:10.21203/rs.3.rs-1025464/v1
Hypertension in the Young Adult
Witte, K. K., & Jamil, H. A. (2015) · Springer eBooks · doi:10.1007/978-1-4471-2789-5_11
Dysglycemia in patients with Acromegaly and Cushing’s syndrome
Asbar, H., Jaafari, F. Z. E., Rafi, S., Mghari, G. E., & Ansari, N. E. (2022) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2022.13.1.0054
Clinical, Laboratory, and Radiological Diagnosis of Hypercortisolism
Guido, P., & Zamora, C. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-87189-5_4
Endocrine Hypertensive Emergencies
Egan, C. E., Greenberg, J. A., & Fahey, T. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-84737-1_42
(2009) · Hypertension Research · doi:10.1038/hr.2008.15
Tovar, A. P., Abreu-Lomba, A., Arenas-Quintero, H. M., Giraldo, C. M. G., Pantoja, D., Valenzuela, Á., Ramos, A. F. G., & Gómez, N. B. (2022) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.9.3.738
Pereira, A. M., & Dekkers, O. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00006-8
Electrocardiographic Manifestations of Endocrine and Metabolic Disorders
Amini, M., Golchin, N., Kharat, M., Mahmood, A., & Sachmechi, I. (2023) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2023.137010
Long-term complications of hypercortisolism
Pivonello, R., Crescenzo, E. M., Simeoli, C., Paola, N. D., Larocca, A., & Colao, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00123-0
Long-term outcomes of the patients with Cushing syndrome after endocrine remission
Akkuş, G., Aksoydan, Ü. P., Odabaş, F., Coşkun, N. S. Ş., Tetıker, T., & Sert, M. (2024) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1501540
Ferrière, A., & Tabarin, A. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.07.002
Hyperglycémie induite par l’analogue de somatostatine pasiréotide au cours de la maladie de Cushing
Reznik, Y., Bisot-Locard, S., & Vergès, B. L. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30072-9
Hsiao, I.-T., & Lu, C.-H. (2026) · Cureus · doi:10.7759/cureus.103162
Metabolic syndrome in cushing’s syndrome patients: Does gender matter?
Ferraù, F., Acanfora, M., Pirchio, R., Ricci, F., Verrienti, M., Blanca, E. S., Frara, S., Gatto, F., Auriemma, R. S., & Colao, A. (2026) · Pituitary · doi:10.1007/s11102-026-01644-2
Chasseloup, F. (2022) · theses.fr (ABES) · doi:10.70675/ddec5b6dzf376z4aadz9970zf0bf052c6f02
Morgante, C., Cammà, C., PETTA, S., Guarnotta, V., & Arnaldi, G. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i16.116142
Self-citationReferral to Definitive Surgical Treatment in Cushing's Syndrome – An Odyssey That Requires Attention
Coulden, A., Arshad, A., Diddhenipothage, S. A. D. M., Aylwin, S. J. B., Mamoojee, Y. H., Flanagan, D., Pal, A., Gittoes, N. J. L., & Gleeson, H. K. (2026) · Clinical Endocrinology · doi:10.1111/cen.70175
If it is in the adrenal gland, it is not essential (hypertension)
Kramm, C., & Lockette, W. E. (2026) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2026.102133
Fichna, M., Fichna, P., Sumińska, M., Gębarski, B., & Ruchała, M. (2026) · Clinical Endocrinology · doi:10.1111/cen.70203
Riesgo vascular en enfermedades endocrinológicas distintas a la diabetes
Martín-Portugués, I. A., Cuende, J. I., López-Guerrero, J. N., & Valdivielso, P. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.05.001
Metadata
- Authors
- Mancini, T., Kola, B., Mantero, F., Boscaro, M., & Arnaldi, G.
- Affiliations
- Marche Polytechnic University (IT)
- University of Padua (IT)
- Corresponding author
- Arnaldi, Giorgio
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 61
- Issue
- 6
- Pages
- 768-777
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2103539163
- Cited by
- 278
- References
- 40
- Citations by year
- 2026: 11 · 2025: 6 · 2024: 13 · 2023: 8 · 2022: 16 · 2021: 12 · 2020: 15 · 2019: 10 · 2018: 16 · 2017: 15 · 2016: 15 · 2015: 24 · 2014: 15 · 2013: 15 · 2012: 17
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- Cushing's syndrome, cardiovascular risk, hypertension, diabetes mellitus, obesity, hyperlipidemia, left ventricular hypertrophy, proteinuria, hypercortisolism, disease duration, pituitary adenoma, adrenal adenoma, Cushing's disease, cardiovascular risk factors
- MeSH terms
- Adult, Cardiovascular Diseases, Cushing Syndrome, Diabetes Mellitus, Female, Humans, Hyperlipidemias, Hypertension, Male, Middle Aged, Obesity, Risk, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
